PMID- 8731525
OWN - NLM
STAT- MEDLINE
DCOM- 19961002
LR  - 20131121
IS  - 0006-3223 (Print)
IS  - 0006-3223 (Linking)
VI  - 39
IP  - 9
DP  - 1996 May 1
TI  - Adverse symptomatology and suicide associated with the use of 
      methylenedioxymethamphetamine (MDMA; "Ecstasy").
PG  - 819-20
FAU - Cohen, R S
AU  - Cohen RS
LA  - eng
PT  - Case Reports
PT  - Journal Article
PL  - United States
TA  - Biol Psychiatry
JT  - Biological psychiatry
JID - 0213264
RN  - 0 (Hallucinogens)
RN  - KE1SEN21RM (N-Methyl-3,4-methylenedioxyamphetamine)
SB  - IM
MH  - Adolescent
MH  - Adult
MH  - Combined Modality Therapy
MH  - Depressive Disorder/chemically induced/psychology/rehabilitation
MH  - Female
MH  - Hallucinogens/administration & dosage/*adverse effects
MH  - Humans
MH  - Male
MH  - N-Methyl-3,4-methylenedioxyamphetamine/administration & dosage/*adverse effects
MH  - Substance-Related Disorders/*psychology/rehabilitation
MH  - Suicide/*psychology
EDAT- 1996/05/01 00:00
MHDA- 1996/05/01 00:01
CRDT- 1996/05/01 00:00
PHST- 1996/05/01 00:00 [pubmed]
PHST- 1996/05/01 00:01 [medline]
PHST- 1996/05/01 00:00 [entrez]
AID - 0006-3223(95)00551-X [pii]
AID - 10.1016/0006-3223(95)00551-X [doi]
PST - ppublish
SO  - Biol Psychiatry. 1996 May 1;39(9):819-20. doi: 10.1016/0006-3223(95)00551-X.